Piramal Pharma Statistics

Total Valuation

Piramal Pharma has a market cap or net worth of INR 319.37 billion. The enterprise value is 363.15 billion.

Market Cap	319.37B
Enterprise Value	363.15B

Important Dates

The next estimated earnings date is Wednesday, January 22, 2025.

Earnings Date	Jan 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+9.21%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	607.58M

Valuation Ratios

The trailing PE ratio is 704.55.

PE Ratio	704.55
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	8.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.11, with an EV/FCF ratio of -1,169.95.

EV / Earnings	801.13
EV / Sales	4.17
EV / EBITDA	26.11
EV / EBIT	55.42
EV / FCF	-1,169.95

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.61.

Current Ratio	1.03
Quick Ratio	0.43
Debt / Equity	0.61
Debt / EBITDA	3.61
Debt / FCF	-154.20
Interest Coverage	1.36

Financial Efficiency

Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 2.95%.

Return on Equity (ROE)	0.58%
Return on Assets (ROA)	2.46%
Return on Capital (ROIC)	2.95%
Revenue Per Employee	12.95M
Profits Per Employee	67,465
Employee Count	6,719
Asset Turnover	0.58
Inventory Turnover	1.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +68.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+68.05%
50-Day Moving Average	253.32
200-Day Moving Average	199.49
Relative Strength Index (RSI)	47.02
Average Volume (20 Days)	290,871

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Piramal Pharma had revenue of INR 87.04 billion and earned 453.30 million in profits. Earnings per share was 0.34.

Revenue	87.04B
Gross Profit	52.36B
Operating Income	5.90B
Pretax Income	3.22B
Net Income	453.30M
EBITDA	12.87B
EBIT	5.90B
Earnings Per Share (EPS)	0.34

Full Income Statement

Balance Sheet

The company has 4.08 billion in cash and 47.86 billion in debt, giving a net cash position of -43.78 billion.

Cash & Cash Equivalents	4.08B
Total Debt	47.86B
Net Cash	-43.78B
Net Cash Per Share	n/a
Equity (Book Value)	79.07B
Book Value Per Share	59.51
Working Capital	1.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.81 billion and capital expenditures -7.12 billion, giving a free cash flow of -310.40 million.

Operating Cash Flow	6.81B
Capital Expenditures	-7.12B
Free Cash Flow	-310.40M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.15%, with operating and profit margins of 6.77% and 0.52%.

Gross Margin	60.15%
Operating Margin	6.77%
Pretax Margin	3.70%
Profit Margin	0.52%
EBITDA Margin	14.79%
EBIT Margin	6.77%
FCF Margin	n/a

Dividends & Yields

Piramal Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-9.21%
Shareholder Yield	-9.21%
Earnings Yield	0.14%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a